Pure and Applied Chemistry

Pure Appl. Chem., 2007, Vol. 79, No. 9, pp. 1521-1530

http://dx.doi.org/10.1351/pac200779091521

Biologically active polymeric sequestrants: Design, synthesis, and therapeutic applications

References

• 1. R. Duncan. Nat. Rev. Drug Discov. 2, 347 (2003). (http://dx.doi.org/10.1038/nrd1088)
• 2. R. Langer, D. A. Tirrell. Nature 428, 487 (2004). (http://dx.doi.org/10.1038/nature02388)
• 3. Y. Luo, G. D. Prestwish. Curr. Cancer Drug Targets 2, 209 (2002). (http://dx.doi.org/10.2174/1568009023333836)
• 4. R. Langer. Nature 392, 5 (1998).
• 5. C. V. Uglea, L. Panaitescu. Curr. Trends Polym. Sci. 2, 241 (1997).
• 6. M. Mammen, S. K. Choi, G. M. Whitesides. Angew. Chem., Int. Ed. 37, 2754 (1998). (http://dx.doi.org/10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3)
• 7. R. Haag, F. Kratz. Angew. Chem., Int. Ed. 45, 1198 (2006). (http://dx.doi.org/10.1002/anie.200502113)
• 8. R. Duncan. In Polymeric Drug Delivery Systems, G. S. Kwon (Ed.), p. 1, Marcel Dekker, New York (2005).
• 9. I. B. Salusky, W. G. Goodman. Nephrol. Dial. Transplant. 15, 1738 (2000). (http://dx.doi.org/10.1093/ndt/15.11.1738)
• 10. A. Bellasi, L. Kooienga, G. A. Block. Hemodial. Int. 10, 225 (2006). (http://dx.doi.org/10.1111/j.1542-4758.2006.00100.x)
• 11. F. P. Schmidtchen, M. Berger. Chem. Rev. 97, 1609 (1997). (http://dx.doi.org/10.1021/cr9603845)
• 12. J. M. Lehn. Angew. Chem., Int. Ed. 27, 89 (1988). (http://dx.doi.org/10.1002/anie.198800891)
• 13. B. Dietrich. Pure Appl. Chem. 65, 1457 (1993).
• 14. S. R. Holmes-Farley, W. H. Mandeville. U.S. Patent 6 726 905 (2004).
• 15. S. R. Holmes-Farley, W. H. Mandeville, J. Ward, K. L. Miller. J. Macromol. Sci., Pure Appl. Chem. A36, 1085 (1999).
• 16. N. Amin. Nephrol. Dial. Transplant. 17, 340 (2002). (http://dx.doi.org/10.1093/ndt/17.2.340)
• 17. A. J. Bleyer, J. Balwit. Therapy 2, 823 (2005). (http://dx.doi.org/10.1586/14750708.2.6.823)
• 18. R. R. Crichton. Inorganic Biochemistry of Iron Metabolism, Ellis Harwood, New York (1991).
• 19. D. H. Boldt. Am. J. Med. Sci. 318, 207 (1999). (http://dx.doi.org/10.1097/00000441-199910000-00001)
• 20. D. J. Weatherall, J. B. Clegg. The Thalassaemia Syndromes, 3rd ed., Blackwell Scientific, Oxford (1981).
• 21. J. A. Cuthbert. J. Invest. Med. 45, 518 (1997).
• 22. Z. D. Liu, R. C. Hider. Med. Res. Rev. 26, 64 (2002).
• 23. M. J. Miller. Chem. Rev. 89, 1563 (1989). (http://dx.doi.org/10.1021/cr00097a011)
• 24. W. H. Mandeville, S. R. Holmes-Farley. U.S. Patent 5 487 888 (1994).
• 25. S. C. Polomoscanik, C. P. Cannon, T. X. Neenan, S. R. Holmes-Farley, W. H. Mandeville, P. K. Dhal. Biomacromolecules 6, 2946 (2005). (http://dx.doi.org/10.1021/bm050036p)
• 26. T. Zhou, H. Neubert, D. Y. Liu, Z. D. Liu, Y. M. Ma, X. L. Kong, W. Luo, S. Mark, R. C. Hider. J. Med. Chem. 49, 4171 (2006). (http://dx.doi.org/10.1021/jm0600949)
• 27. M. A. Denke, C. T. Sempos, S. M. Grundy. Arch. Int. Med. 153, 1093 (1993). (http://dx.doi.org/10.1001/archinte.153.9.1093)
• 28. S. M. Jamal, M. J. Eisenberg, S. Christopoulos. Am. Heart J. 147, 956 (2004). (http://dx.doi.org/10.1016/j.ahj.2003.12.037)
• 29. E. R. Stedronsky. Biochim. Biophys. Acta 1210, 255 (1994).
• 30. W. H. Mandeville, D. I. Goldberg. Curr. Pharm. Des. 3, 15 (1997).
• 31. C. C. Huval, S. R. Holmes-Farley, W. H. Mandeville, R. Sacchiero, P. K. Dhal. Eur. Polym. J. 40, 693 (2004). (http://dx.doi.org/10.1016/j.eurpolymj.2003.11.012)
• 32. L. Zhang, V. Janout, J. L. Renner, M. Uragami, S. L. Regen. Bioconjugate Chem. 11, 397 (2000). (http://dx.doi.org/10.1021/bc990151v)
• 33. C. C. Huval, M. J. Bailey, S. R. Holmes-Farley, W. H. Mandeville, R. Sacchiero, P. K. Dhal. J. Macromol. Sci., Pure Appl. Chem. A38, 1559 (2001).
• 34. C. C. Huval, M. J. Bailey, W. H. Braunlin, S. R. Holmes-Farley, W. H. Mandeville, J. S. Petersen, S. C. Polomoscanik, R. J. Sacchiro, X. Chen, P. K. Dhal. Macromolecules 34, 1548 (2001). (http://dx.doi.org/10.1021/ma001898f)
• 35. N. S. Cameron, A. Eisenberg, G. R. Brown. Biomacromolecules 3, 116 (2002). (http://dx.doi.org/10.1021/bm015595k)
• 36. K. L. Steinmetz, K. S. Schonder. Cardiovasc. Drug Rev. 23, 15 (2005).
• 37. B. Henderson, M. Wilson, B. Wren. Trends Microbiol. 5, 454 (1997). (http://dx.doi.org/10.1016/S0966-842X(97)01125-6)
• 38. E. A. Coyle. Pharmacotherapy 23, 638 (2003). (http://dx.doi.org/10.1592/phco.23.5.638.32191)
• 39. C. P. Kelly, T. LaMont. Annu. Rev. Med. 19, 375 (1998). (http://dx.doi.org/10.1146/annurev.med.49.1.375)
• 40. L. L. Kiessling, J. E. Gestwicki, L. E. Strong. Curr. Opin. Chem. Biol. 4, 696 (2000). (http://dx.doi.org/10.1016/S1367-5931(00)00153-8)
• 41. W. Braunlin, Q. Xu, P. Hook, R. Fitzpatrick, J. D. Klinger, R. Burrier, C. B. Kurtz. Biophys. J. 87, 534 (2004). (http://dx.doi.org/10.1529/biophysj.104.041277)
• 42. P. K. Dhal, S. R. Holmes-Farley, C. C. Huval, T. H. Jozefiak. Adv. Polym. Sci. 192, 9 (2006).